This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignee: The University of Toledo. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Discovering Innovations by Jeffrey P. Demuth
Introduction
Jeffrey P. Demuth, an innovative inventor based in Blanchester, OH, has made significant contributions to the field of oncology. With a focus on non-small cell lung cancer (NSCLC), his work exemplifies the merging of genetic research and practical treatment methodologies.
Latest Patents
Jeffrey P. Demuth holds a patent for a "Method for selecting a treatment for non-small cell lung cancer using gene expression profiles." This groundbreaking invention aims to identify and quantify changes in gene expression associated with NSCLC by examining tissues from both normal and diseased lungs. The patent outlines methods to determine gene expression profiles that serve as diagnostic markers, helping to monitor disease states, progression, drug toxicity, efficacy, and metabolism.
Career Highlights
Demuth's career is marked by his role at the University of Toledo, where he leverages his expertise in genetic research to further the understanding of lung cancer treatments. His work is crucial in developing tailored approaches to patient care through the application of gene expression analysis.
Collaborations
Throughout his career, Jeffrey has worked alongside notable colleagues, including Erin Crawford and James C. Willey. These collaborations highlight the importance of teamwork in advancing research and innovations in cancer treatment.
Conclusion
Jeffrey P. Demuth's work exemplifies the power of innovation in addressing critical health challenges. Through his patent and ongoing research, he continues to contribute valuable knowledge that enhances our understanding and treatment of non-small cell lung cancer. His commitment to improving patient outcomes embodies the spirit of invention in the medical field.